Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S.

Here is some background information about stem cells. Scientists believe that stem cell research can be used to treat medical conditions including Parkinson’s disease, spinal cord injury, stroke, ...

The phase 2 study – reported at the Conference on Retroviruses and Opportunistic Infections (CROI) in Denver, Colorado – looked at the combination of MSD’s experimental long-acting reverse ...

Other confirmed 2025 events include tech firms events Aveva World 2025, Figma’s Config and HubSpot’s Inbound, as well as the Conference on Retroviruses and Opportunistic Infections.

Following an initial announcement of positive results last year, detailed data from the two trials has been presented at the annual Conference on Retroviruses and Opportunistic Infections (CROI).

Here’s a look at the origins, treatments and global response to HIV and AIDS. Facts HIV stands for human immunodeficiency virus. AIDS stands for acquired immunodeficiency syndrome. HIV/AIDS is spread ...

In 2021, approval of cabotegravir (Apretude) as the first long-acting PrEP option provided patients an option to move from ...

Exploring caregiver dependence and social determinants of health reveals critical barriers to HIV care for children, ...

Transposable elements contribute to evolution, but their own diversification remains incompletely understood. Here, insect ...

The conference highlighted recent issues in vaccine safety, including the history and design of a vaccine for rotavirus. Other topics included discussions of the synergies between veterinary and ...

The FDA warns that listeria can cause listeriosis, a serious infection especially dangerous for pregnant women, newborns, older adults and people with weakened immune systems. In severe cases ...

Conference media days are still two months away, but the offseason buzz for 2025 will pick up with release of the Athlon Sports College Football preview magazine later this month. With rosters and ...